• Overview
  • Details
  • More
Share Products Categories Channel Cart
1/6
Best Selling Reliable Quality Raw Material 99% Powder CAS 302-79-4 Vitamin a Acid/Tretinoin/Retinoic Acid for Skincare图1Best Selling Reliable Quality Raw Material 99% Powder CAS 302-79-4 Vitamin a Acid/Tretinoin/Retinoic Acid for Skincare图2Best Selling Reliable Quality Raw Material 99% Powder CAS 302-79-4 Vitamin a Acid/Tretinoin/Retinoic Acid for Skincare图3Best Selling Reliable Quality Raw Material 99% Powder CAS 302-79-4 Vitamin a Acid/Tretinoin/Retinoic Acid for Skincare图4Best Selling Reliable Quality Raw Material 99% Powder CAS 302-79-4 Vitamin a Acid/Tretinoin/Retinoic Acid for Skincare图5Best Selling Reliable Quality Raw Material 99% Powder CAS 302-79-4 Vitamin a Acid/Tretinoin/Retinoic Acid for Skincare图6

Best Selling Reliable Quality Raw Material 99% Powder CAS 302-79-4 Vitamin a Acid/Tretinoin/Retinoic Acid for Skincare

Price $8.50
Min Order 10 grams  
Shipping from Jiangsu, China
Quantity
-+
Product details
A-38
Skin Care
Acne Treatment
Retinoic Acid
Female
MSDS, Coa
Two Years
Normal Temperature
-
Available
10g
2 Years
HPLC
99%
Yellow Powder
PE Bag+Aluminum Foil Bag
Cool&Dry Places
302-79-4
C20h28o2
300.44
Cosmetic&Pharmaceutical Grade
Cosmetic&Pharmaceutical
Greenway
ISO
Greenway
1kg/Bag; 25kg/Drum
1kg/Bag; 25kg/Drum
Jiangsu
2942000000
Product Description

Product NameRetinoic Acid
Other NamesVitamin A Acid/Tretinion/Tretinoin
CAS No.302-79-4
Molecular FormulaC20H28O2
Molecular Weight300.44
AppearanceYellow Powder
Assay99%
GradeCosmetic&Pharmaceutical Grade
Brand NameGreenway

Product Introduction:

Tretinoin is the acid form of vitamin A and is also known as all-trans retinoic acid or ATRA. It is a drug commonly used to treat acne vulgaris and keratosis pilaris. It is available as a cream or gel It is also used to treat acute promyelocytic leukemia. It is also available as a generic.

 

Its success in treating acute promyelocytic leukemia was a major breakthrough in the treatment of this type of leukemia.It works in APL because the majority of cases involve a chromosomal translocation of chromosomes 15 and 17, which causes genetic fusion of the retinoic acid receptor gene to the promyelocytic leukemia  gene.

 

This fusion PML-RAR protein is responsible for preventing immature myeloid cells from differentiating into more mature cells. This block in differentiation is thought to cause leukemia.

 

ATRA acts on PML-RAR to lift this block, causing the immature promyelocytes to differentiate to normal mature blood cells thus decreasing promyelocytes.












Buyer review
Loading review details...
Contact

Suzhou Greenway Biotech Co., Ltd.

Audited Supplier9 Years
ProfileCertified by SGS/BV

Message Type

* Content

* Name

* Phone

* Email

* Captcha

captcha

Recommended for you